Jpmorgan Chase & CO Nutri Band Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
18Shares Held
284KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA118KShares$517,1150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.1KShares$254,3150.0% of portfolio
-
Ubs Group Ag20.4KShares$89,1410.0% of portfolio
-
Avantax Advisory Services, Inc.18.7KShares$81,8090.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$75,6250.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $34.2M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...